IMR Press / FBL / Volume 14 / Issue 12 / DOI: 10.2741/3557

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
Russian thistle pollinosis: form allergen characterization to specific immunotherapy treatment
Show Less
1 Servicio de Alergia, Hospital Clinico Universitario “Lozano Blesa”, Av. San Juan Bosco 15, 50009-Zaragoza. Spain

Academic Editor: Ernesto Enrique

Front. Biosci. (Landmark Ed) 2009, 14(12), 4652–4657;
Published: 1 January 2009
(This article belongs to the Special Issue New insights in diagnosis and treatment of allergic diseases)

Chenopodiacea/Amaranthacea pollen is an important cause of respiratory allergy around the world. The problem could be aggravated because in desert or desert-like countries, these weeds are used in greening programmes or as ornamental plants. As climate tendencies should maintain in future decades, relevance of Chenopodiacea/Amaranthacea pollen allergy will go up. Relationship between airborne pollen grains and symptoms may not follow conventional patterns, and a wide lag between pollen counts and symptoms has been observed. Allergens from Chenopodium album y Salsola kali are probably the best known. A mayor band protein of 40-43 kDa has been associated with the main Salsola kali allergen, named sal k 1 and now recognised as pectin methyltranspherase or glucose 3 phosphate dehidrogenase. Systemic immunotherapy is effective and safe, improving symptoms, medication intake and Quality of Life and also reduces cutaneous allergen response.

Back to top